Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Metabolomics may be key to identifying diabetes-related kidney disease

Metabolomics, the study of small molecules the body produces during metabolism (metabolites) may be a future key to identifying diabetes-related kidney disease.

24 Jun 2019

MSK receives approval for new molecular assay from New York State Department of Health

Memorial Sloan Kettering Cancer Center announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status.

24 Jun 2019

Most women glad to do genetic testing before IVF, reports survey

The most effective way to increase the odds that an embryo will successfully implant during in vitro fertilization is genetic testing to see if the embryo is normal.

21 Jun 2019

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

Research supported by the Accelerating Medicines Partnership on Rheumatoid Arthritis and Systemic Lupus Erythematosus provides new insights into tissue damage for these autoimmune conditions.

19 Jun 2019

Machine learning algorithms applied to biopsy images can improve gut disease diagnosis

A study published in the open access journal JAMA Open Network June 14 by scientists at the University of Virginia schools of Engineering and Medicine and the Data Science Institute says machine learning algorithms applied to biopsy images can shorten the time for diagnosing and treating a gut disease that often causes permanent physical and cognitive damage in children from impoverished areas.

18 Jun 2019

Genetic study on liver iron content may pave way for better treatment

High levels of iron in the liver are linked to a number of serious health conditions including cancer, diabetes, high blood pressure and cardiovascular as well as liver disease. But measuring liver iron is difficult and until recently could only be done through an invasive biopsy.

17 Jun 2019

Combining expansion microscopy with VR allows researchers to 'step inside' biological data

A combined research team from Carnegie Mellon University and Benaroya Research Institute at Virginia Mason is pairing a nanoscale imaging technique with virtual reality technology to create a method that allows researchers to "step inside" their biological data.

14 Jun 2019

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.

13 Jun 2019

Disease-modifying therapy for Alport syndrome still remains an unmet need

Alport syndrome is a hereditary type IV collagen disease that leads to progressive proteinuria, renal fibrosis, and kidney failure.

13 Jun 2019

New 'virtual biopsy' device developed to detect skin tumors

Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new "virtual biopsy" device that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.

13 Jun 2019

UAMS-developed noninvasive device detects melanoma in earliest stages

A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to detect and kill circulating tumor cells in the blood using a noninvasive device called Cytophone that integrates a laser, ultrasound and phone technologies.

13 Jun 2019

UCLA physicians find more effective method for detecting prostate cancer

Each year, 1 million men in the U.S. undergo biopsies to determine whether they have prostate cancer. The biopsy procedure traditionally has been guided by ultrasound imaging, but this method cannot clearly display the location of tumors in the prostate gland.

12 Jun 2019

Study aims at developing new therapies to fight childhood cancer

Researchers from the Department of Cellular Biology at the University of Seville and the Seville Institute of Biomedicine, Pablo Vicente and Doctor Luisma Escudero, in close collaboration with the researcher Rebecca Burgos and other members of the group of Doctor Rosa Noguera have published a study aimed at developing new therapies to fight childhood cancer.

12 Jun 2019

Never say ‘die’: Why so many doctors won’t break bad news

After nearly 40 years as an internist, Dr. Ron Naito knew what the sky-high results of his blood test meant. And it wasn't good.

12 Jun 2019

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer.

11 Jun 2019

World’s first clinical guidance on anal sex after prostate cancer treatments

UK doctors and surgeons have formulated what is probably the world's first clinical guidance on anal sex before, during, and after diagnosis and treatment for prostate cancer.

10 Jun 2019

Prostate cancer diagnosis gets a boost from MRI

Traditionally prostate cancers have been diagnosed using biopsies of the tumour masses. New research from researchers at University College London (UCL) has shown that a more accurate diagnostic means for prostate cancers is MRI scans and targeted biopsies.

9 Jun 2019

Study shows both IDH-mutant WHO-defined molecular subgroups could benefit from PCV chemoradiotherapy

A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.

3 Jun 2019

Only few prostate cancer patients choosing active surveillance follow monitoring guidelines

Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that just 15 percent of a group of men in North Carolina with early-stage prostate cancer who choose active surveillance instead of treatment followed the recommended monitoring guidelines.

3 Jun 2019

Research finds link between Toxoplasma gondii and lung cancer

Toxoplasma gondii, a microscopic parasite that gets inside our cells, is present in about 10% of the population in the UK.

30 May 2019

Biopsy News and Research

Further Reading

Metabolomics may be key to identifying diabetes-related kidney disease

MSK receives approval for new molecular assay from New York State Department of Health

Most women glad to do genetic testing before IVF, reports survey

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

Machine learning algorithms applied to biopsy images can improve gut disease diagnosis

Genetic study on liver iron content may pave way for better treatment

Combining expansion microscopy with VR allows researchers to 'step inside' biological data

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

Disease-modifying therapy for Alport syndrome still remains an unmet need

New 'virtual biopsy' device developed to detect skin tumors

UAMS-developed noninvasive device detects melanoma in earliest stages

UCLA physicians find more effective method for detecting prostate cancer

Study aims at developing new therapies to fight childhood cancer

Never say ‘die’: Why so many doctors won’t break bad news

Using molecular biomarkers to guide the choice of therapies for metastatic pancreatic cancer

World’s first clinical guidance on anal sex after prostate cancer treatments

Prostate cancer diagnosis gets a boost from MRI

Study shows both IDH-mutant WHO-defined molecular subgroups could benefit from PCV chemoradiotherapy

Only few prostate cancer patients choosing active surveillance follow monitoring guidelines

Research finds link between Toxoplasma gondii and lung cancer

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News